Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: A randomized clinical trial

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 5, 2010, Pages 1028-1035

  Roushan, M R Hasanjani ^a   Amiri, M J Soleimani ^a   Janmohammadi, N ^a   Sadeghi Hadad, M ^a   Javanian, M ^a   Baiani, M ^a   Bijani, A ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aminoglycosides; Malta fever; RCT; Therapy regimen

Indexed keywords

DOXYCYCLINE; GENTAMICIN; STREPTOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL DISCOMFORT; ADOLESCENT; ADULT; ARTICLE; BRUCELLOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EPIGASTRIC PAIN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONYCHOLYSIS; OTOTOXICITY; PHOTOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; TREATMENT DURATION; COMPARATIVE STUDY; DRUG COMBINATION; INTRAMUSCULAR DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; BRUCELLOSIS; DOXYCYCLINE; DRUG THERAPY, COMBINATION; FEMALE; GENTAMICINS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; RECURRENCE; STREPTOMYCIN; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953725579     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq064     Document Type: Article

References (27)

1. Young EJ. An overview of human brucellosis. Clin Infect Dis 1995; 21: 283-90.
2. Colmenero JD, Reguera JM, Martos F et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine 1996; 75: 195-211.
3. Food and Agriculture Organization, WHO. Joint FAO-WHO expert committee on brucellosis, sixth report. In: World Health Organization Technical Report Series 740. Geneva: WHO, 1986.
4. Colmenero Castillo JD, Hernandez Marquez S, Reguera Iglesias JM et al. A comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis. Chemotherapy 1989; 35: 146-52.
5. Cisneros JM, Viciana P, Colmenero J et al. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks. Antimicrob Agents Chemother 1990; 34: 881-3.
6. Pappas G, Solera J, Akritidis N et al. New approaches to the antibiotic treatment of brucellosis. Int J Antimicrob Agents 2005; 26: 101-5.
7. Acocella G, Bertrand A, Baytout J et al. Comparison of three different regimens in the treatment of acute brucellosis: a multinational study. J Antimicrob Chemother 1989; 23: 433-9.
8. Solera J, Rodriguez-Zapata M, Geijo P et al. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob Agents Chemother 1995; 39: 2061-7.
9. Solera J, Martinez-Alfaro E, Espinoza A. Recognition and optimum treatment of brucellosis. Drugs 1997; 53: 245-56.
10. Montejo JM, Alberola I, Gonzalez-Zarate P et al. Open randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin Infect Dis 1993; 16: 671-6.
11. Al-Hajjaj MS, Al-Kassimi FA, Al-Mobeireek AF et al. Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia. Respirology 2001; 6: 317-22.
12. Masjedi MR, Farina P, Sorooch S et al. Extensive drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis 2007; 44: 888-9.
13. Roushan MR, Smailnejad Gangi SM, Asgharzadeh Ahmadi SA. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis. Swiss Med Wkly 2004; 134: 564-8.
14. al-Eissa YA, Kambal AM, al-Nassar MN et al. Childhood brucellosis: a study of 102 cases. Pediatr Infect Dis J 1990; 9: 74-9.
15. Ariza J, Bosilkovski M, Casio A et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 2007; 4: e317.
16. Solera J, Espinosa A, Geijo P et al. Treatment of human brucellosis with netilmicin and doxycycline. Clin Infect Dis 1996; 22: 441-5.
17. Solera J, Medrano F, Rodriguez M et al. A comparative therapeutic and multicenter trial of rifampin and doxycycline versus streptomycin and doxycycline in human brucellosis. Med Clin Barc 1997; 96: 649-53.
18. Lulu AR, Araj GF, Khateeb MI. Human brucellosis in Kuwait: a prospective study of 400 cases. Q J Med 1988; 249: 39-54.
19. Hasanjani Roushan MR, Mohraz M, Hajiahmadi M et al. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis 2006; 42: 1075-80.
20. Solera J, Geijo P, Largo J et al. A randomized, double blind study to assess the optimal duration of doxycycline treatment for human brucellosis. Clin Infect Dis 2004; 39: 1776-82.
21. Solera J, Espinosa A, Martinez-Alfaro E et al. Treatment of human brucellosis with doxycycline and gentamicin. Antimicrob Agents Chemother 1997; 41: 80-4.
22. Lubani MM, Dudin KI, Sharda DC et al. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J 1989; 8: 75-8.
23. Corbel MJ, Beeching NJ. Brucellosis. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jamieson JL, eds. Harrison's Principles of Internal Medicine, 16th edn. New York: McGraw-Hill Company, 2005; 914-7.
24. Young EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 6th edn. Philadelphia: Churchill Livingstone, 2005; 2669-74.
25. Solera J, Lozano E, Martinez-Alfaro E et al. Brucellar spondylitis: review of 35 cases and literature survey. Clin Infect Dis 1999; 29: 1440-9.
26. Abramson O, Abu-Rashid M, Gorodischer R et al. Failure of short antimicrobial treatments for human brucellosis. Antimicrob Agents Chemother 1997; 41: 1621-2.
27. Sanchez-Tamayo T, Colmenero JD, Martinez-Cortes F et al. Failure of short-term antimicrobial therapy in childhood brucellosis. Pediatr Infect Dis J 1997; 16: 323-4.